FXM Research Miramar   Report issue

For profit Phase 4
Founded: Miramar FL United States (2007)

Organization Overview

First Clinical Trial
2010
NCT01138735
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now